StonvexLoading…
StonvexStonvexStonvexCore line items from SCOR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $357.47M | $356.05M | $371.34M | $376.42M |
Operating Income | $4.51M | $-59.51M | $-73.60M | $-74.87M |
Net Income | $-10.00M | $-60.25M | $-79.36M | $-66.56M |
EPS (Diluted) | $4.25 | $-15.53 | $-19.88 | $-17.71 |
Total Assets | $407.71M | $430.25M | $491.30M | $580.59M |
Total Liabilities | $206.55M | $231.04M | $247.31M | $248.54M |
Cash & Equivalents | $23.62M | $29.94M | $22.75M | $20.04M |
Free Cash Flow OCF − CapEx | $21.78M | $17.29M | $27.35M | $33.80M |
Shares Outstanding | 14.88M | 4.89M | 4.76M | 4.61M |